medigraphic.com
ISSN 1405-8790 (Print)

2011, Number 2

<< Back

Rev Mex Med Fis Rehab 2011; 23 (2)

Unilateral blepharoptosis due to vanity: A diagnostic challenge

Domínguez-Gasca LG, Domínguez-Carrillo LG

Language: Spanish
References: 31
Page: 67-72
PDF size: 98.53 Kb.


ABSTRACT

Introduction: In 1950 Vernon Brooks demonstrates that the botullinum toxin blocks the release of acetylcholine of the motoneurones; during the sixties Scout starts to apply his knowledge to treat strabismus; in 2002 is approved for esthetic treatments, when it is infiltrated at the periorbital zone the most frequently side effect reported is blepharoptosis. Clinic case: 56 years old female patient; suffering a whiplash during an automobile crash, she was treated with orthosis and sent to rehabilitation service, three days after the crash she presented unilateral left blepharoptosis and hypoesthesia in T8-D1 ipsilateral territory; she denied the usage of botullinum toxin. Physical features: partial left blepharoptosis, with consensual, accommodation and photomotor normal reflexs and isochoric pupils; her radiographies show discarthrosis C5-C6; magnetic resonance: C4-C5, C5-C6 discs herniations and C4-C5 retrolisthesis. She refused surgical treatment and returned back to rehabilitation for treatment during 4 months; the patient was discharged asymptomatic, finally accepting the use of botullinum toxin one day before the crash. Conclusions: Blepharoptosis is a challenger diagnosis because there are about one hundred different causes.


REFERENCES

  1. Bulloch W. History. In: Medical Research Council. A system of bacteriology in relation to medicine London. His Majesty’s Stationery Offic; 1929; III(XI): 373-374.

  2. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044-1049.

  3. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186-1194.

  4. Ascher B, Rossi B. Botulinum toxin and wrinkles: few side effects and effective combining procedures with other treatments. Ann Chir Plast Esthet 2004; 49: 537-553.

  5. Wollina U, Konrad H. Managing adverse events associated with botulinum toxin type A: a focus on cosmetic procedures. Am J Clin Dermatol 2005; 6: 141-150.

  6. Kim DW, Cundiff J, Toriumi DM. Botulinum toxin A for treatment of lateral periorbital rhytids. Facial Plast Surg Clin North Am 2003; 11: 445-451.

  7. Paloma V, Samper A. A complication with the aesthetic use of Botox: herniation of the orbital fat. Plast Reconstr Surg 2001; 107: 1315-1316.

  8. Prado A, Fuentes P, Guerra C, Leniz P, Wisnia P. Pseudoaneurysm of the frontal branch of the superficial temporal artery: an unusual complication after injection of botox. Plast Reconstr Surg 2007; 119: 2334-2335.

  9. Ortiz PB, Sánchez D, Fernández E, Mesquida M. Ptosis palpebral. Annals Oftalmol 2009; 17: 203-213.

  10. Schmidtke K, Büttner-Ennever JA. Nervous control of eyelid function. A review of clinical experimental and pathological data. Brain 1992; 115: 227-247.

  11. Wong VA, Beckingsale PS, Oley CA, Sullivan TJ. Management of myogenic ptosis. Ophthalmology 2002; 109: 1023-1031.

  12. Baggio E, Ruban JM, Boizard Y. Etiologic causes of ptosis about a serie of 484 cases. To a new classification? J Fr Ophtalmol 2002; 25: 1015-1020.

  13. Kupersmith MJ, Ying G. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment. Br J Ophthalmol 2005; 89: 1330-1334.

  14. Bosco D. Glucose metabolism in the idiopathic blepharoptosis: Utility of the oral glucose tolerance test. And the insulin resistance index. Arch Geront Geriat 2009; 284: 24-28.

  15. Averbuch-Heller L, Leigh RJ, Mermelstein V, Zagalsky L, Streifler JY. Ptosis in patients with hemispheric strokes. Neurology 2002; 58: 620-624.

  16. López P, Casas G, González G, Castro B, Izquierdo G, Castro M. Trombosis de seno cavernoso postraumática. Rev Esp Anestesiol Reanim 2003; 50: 50-51.

  17. Chauhan V, Neg RC, Verma BT. Unilateral blepharospasm and blepharoptosis with bilateral vertical gaze palsy in thalamic hemorrhage. JAPI 2009; 57: 1326-1329.

  18. Esteban A, Traba A, Prieto J. Eyelid movements in health and disease. The supranuclear impairment of the palpebral motility. Neurophysiol Clin 2004; 34: 3-15.

  19. Woong JJ, Chi MJ. Temporary Unilateral Neurogenic Blepharoptosis after Orbital Medial Wall Reconstruction: 3 Cases. Ophthalmologica 2008; 222: 360-362.

  20. Fraunfelder FW, Richards AB. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use. Ophthalmology 2008; 115: 2282-2285.

  21. Lau SC, Shibata SI. Blepharoptosis following oxaliplatin administration. J Oncol Pharm Prac 2010; 15: 255-257.

  22. Yumi T. Two Cases of the Conversion Disorder with Unilateral Blepharoptosis Who Were Suspected of Myasthenia Gravis. J Psyc Med 2001; 41: 49-54.

  23. Miura SM. Centronuclear myopathy presenting unilateral blepharoptosis. A case report. Neurol Med 2000; 53: 479-482.

  24. Khwaja GA. Prolonged, persistent, isolated unilateral ptosis as the initial manifestation of mitochondrial cytopathy. JIACM 2007; 8: 349-351.

  26. Bernardino CR, Rubin PA. Ptosis after cataract surgery. Semin Ophthalmol 2002; 17: 144-148.

  27. Song MS, Shin DH, Spoor TC. Incidence of ptosis following trabeculectomy: a comparative study. Korean J Ophthalmol 1996; 10: 97-103.

  28. McCulley TJ, Robert C, Kersten RC, Chew Yip, CY, Kulwin DR. Isolated unilateral neurogenic blepharoptosis secondary to eyelid trauma. Am J Ophthalmol 2002; 134: 626-627.

  29. Thean HJ, McNab AA. Blepharoptosis in RGP and PMMA hard contact lens wearers Clin Exp Optom 2004; 87(1): 11-14.

  30. Nakauchi K, Kator Ni, Imagawa Y, Yamada T. A case report on lacrimal ductal cyst causing unilateral blepharoptosis. Br J Ophthalmol 2009; 93: 1143-1145.

  31. Putterman AM. Effect of unilateral blepharoptosis on contralateral eyelid position. Ophtal Plastic Rec Sur 2005; 21: 323-324.




2020     |     www.medigraphic.com